Skip to main content
. 2018 Aug 8;10(3):124. doi: 10.3390/pharmaceutics10030124

Figure 4.

Figure 4

Figure 4

Feces, urinary and bile cumulative excretion profile of methyl 3-amino-6-methoxythieno [2,3-b] quinolone-2-carboxylate (PU-48) after single oral dose of 12 mg/kg in rats (n = 6).